HK Neopharm Limited is one of the most reliable manufacturers and suppliers of liraglutide injection in China, featured by quality products and good price. Please rest assured to buy liraglutide injection in stock here and get quotation from our factory. Customized orders are welcome.
Liraglutide Injection (CAS: 204656-20-2) is a human glucagon-like peptide-1 (GLP-1) analog produced by recombinant DNA technology. Through fermentation, multi-step purification, and aseptic filling processes, this high-purity biologic is widely used for the long-term management of type 2 diabetes and obesity (BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity). As a first-line injectable therapy in endocrinology and metabolic diseases, Liraglutide Injection significantly improves glycemic control, reduces body weight, and provides cardiovascular benefits.
If you are looking for China Liraglutide Injection manufacturers, our cGMP-certified facility offers reliable supply. You can **buy Liraglutide Injection** directly from our factory with full quality documentation.
Technical Specifications
|
Product Name |
Liraglutide Injection |
|
Synonyms |
liraglutide 6mg ml |
|
Characteristics |
Colorless or nearly colorless clear liquid |
|
CAS Number |
204656-20-2 |
|
Assay |
≥99.0% (HPLC, Subject to the COA) |
|
Formula |
C172H265N43O51 |
|
Package |
Technical Package |
|
Storage |
Store at 2～8℃ |
|
Structure |
|
As a trusted China Liraglutide Injection supplier, we provide Liraglutide Injection in stock for prompt delivery. Bulk Liraglutide Injection orders are welcome for both API and finished dosage forms.
Product Features
Targeted GLP-1 receptor mechanism
With 97% homology to native human GLP-1, Liraglutide Injection promotes glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and enhances satiety – achieving both glycemic and weight control with very low hypoglycemia risk.
High-purity biologic
State-of-the-art purification ensures purity ≥99.0%, non-pyrogenic, sterile, and consistent bioactivity batch after batch, meeting EMA, FDA, and NMPA standards.
Stable physicochemical properties: Sterile clear solution stable for up to 30 months at 2–8°C; after first use, can be kept at room temperature (≤30°C) protected from light for 30 days.
Once-daily convenience: Prefilled pen with clear dose (0.6 mg, 1.2 mg, 1.8 mg, 3.0 mg) enables high patient adherence.
Proven cardiovascular benefit: The LEADER trial demonstrated a 13% reduction in major adverse cardiovascular events (MACE) in type 2 diabetes patients with cardiovascular disease.
Full-Cycle Quality Control & Consistent Quality
- Raw material control: High-purity Liraglutide API is tested for host cell proteins, residual DNA, endotoxins, etc.
- Closed-loop process monitoring: Fully automated fermentation, chromatography, ultrafiltration, and aseptic filling lines with real-time parameter recording; each pen has a unique serial number for traceability.
- Release testing: Each batch undergoes full testing (appearance, pH, osmolality, content, purity by HPLC, sterility, bacterial endotoxins, particles, bioactivity) and comes with a COA.
- Stability program: Long-term, accelerated, and in-use studies support shelf-life and post-opening quality.
All glutide injections from our facility follow ICH Q7/Q10 guidelines. We also offer Customized Liraglutide Injection packaging and strength options.
Application Scenarios
Liraglutide Injection is indicated for:
Type 2 diabetes mellitus:
As add-on therapy when metformin or sulfonylureas provide insufficient glycemic control – significantly reduces HbA1c and improves β-cell function without increasing hypoglycemia risk.
Obesity and overweight
For initial BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity (hypertension, dyslipidemia, sleep apnea, etc.).
High-cardiovascular-risk diabetic patients
Preferred agent for T2DM patients with ASCVD, heart failure, or chronic kidney disease to reduce cardiogenic death and stroke.
Primary and specialty clinics
Easy-to-use prefilled pen allows home self-injection, reducing hospitalization needs.
When you buy Liraglutide Injection for clinical research or commercial use, our product is Liraglutide Injection made in China with global regulatory compliance.
Packaging and Transportation
Packaging: Medicinal-grade prefilled pen (polypropylene, bromobutyl rubber plunger, stainless steel needle) – 3 ml solution (6 mg/ml). Available in 1 pen/box, 5 pens/box, or 10 pens/box with aluminum foil bag and insert.
Storage: Unopened – 2～8°C refrigerated, protected from light, never freeze. After opening – store at ≤30°C for up to 30 days, do not return to refrigerator.
Cold chain logistics: 2～8°C temperature-controlled shipping with data loggers and cushioning. Phase-change cooling boxes available for remote areas.
Compliance documents: COA, temperature records, export documentation, and instruction manual provided with each shipment.
Our Advantages
API & process advantage
In-house high-purity Liraglutide API (≥99.5%) with patented fermentation and purification processes; stable capacity for both API and finished product.
01
Globally aligned quality system
Our manufacturing base has passed FDA, EMA, and NMPA GMP inspections; products are licensed in multiple countries. Full documentation supports global registrations and audits.
02
Rich clinical evidence
Over 10 years of real-world data, LEADER and SCALE trials confirm long-term safety and efficacy; strongly recommended by ADA, EASD, AACE/ACE.
03
Customized services
Different pen strengths (1.2 mg/ml or 6 mg/ml), custom packaging (e.g., needle-free, special language labels), and regulatory dossiers (DMF, CEP, technical package) available.
04
After-sales support
Professional pharmaceutical team provides product training, cold chain solutions, adverse event monitoring, and literature support.
05
We understand liraglutide injection cost is a key concern for customers. As a direct factory, we offer competitive pricing and flexible Liraglutide Injection Free Sample programs for qualified R&D projects.As a leading China Liraglutide Injection factory, we also supply other glutide injections (e.g., semaglutide, tirzepatide) for combination metabolic therapy R&D.
FAQ
With a well-defined GLP-1 target mechanism, excellent hypoglycemic and weight-loss effects, solid evidence for cardiovascular protection, and a convenient once-daily administration regimen, Liraglutide Injection has become a cornerstone drug in the management of metabolic diseases. We adhere to high-standard production, full-process quality control and flexible customized services, and strive to provide safe, effective and accessible medicinal treatment options for diabetic patients, obese populations and clinicians worldwide. We welcome inquiries and cooperation from all partners to jointly advance the development of metabolic health.
Hot Tags: liraglutide injection, China liraglutide injection manufacturers, suppliers, factory
